BlackRock’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,358,664
| Closed | -$720M | – | 5791 |
|
|
2021
Q2 | $720M | Sell |
4,358,664
-2,268,786
| -34% | -$379M | 0.02% | 764 |
|
|
2021
Q1 | $1.02B | Buy |
6,627,450
+203,083
| +3% | +$27.6M | 0.03% | 574 |
|
|
2020
Q4 | $806M | Buy |
6,424,367
+29,626
| +0.5% | +$3.31M | 0.03% | 618 |
|
|
2020
Q3 | $649M | Sell |
6,394,741
-204,148
| -3% | -$20.8M | 0.02% | 618 |
|
|
2020
Q2 | $642M | Buy |
6,598,889
+321,542
| +5% | +$29.9M | 0.03% | 580 |
|
|
2020
Q1 | $521M | Sell |
6,277,347
-169,703
| -3% | -$16.6M | 0.03% | 590 |
|
|
2019
Q4 | $717M | Sell |
6,447,050
-59,737
| -0.9% | -$6.14M | 0.03% | 608 |
|
|
2019
Q3 | $646M | Buy |
6,506,787
+401,869
| +7% | +$39.9M | 0.03% | 598 |
|
|
2019
Q2 | $605M | Sell |
6,104,918
-106,473
| -2% | -$10.2M | 0.03% | 645 |
|
|
2019
Q1 | $685M | Buy |
6,211,391
+52,524
| +0.9% | +$5.49M | 0.03% | 570 |
|
|
2018
Q4 | $566M | Buy |
6,158,867
+84,557
| +1% | +$8.56M | 0.03% | 583 |
|
|
2018
Q3 | $669M | Buy |
6,074,310
+647,401
| +12% | +$67.4M | 0.03% | 595 |
|
|
2018
Q2 | $507M | Buy |
5,426,909
+1,159,446
| +27% | +$99.8M | 0.02% | 722 |
|
|
2018
Q1 | $354M | Sell |
4,267,463
-83,879
| -2% | -$7.45M | 0.02% | 944 |
|
|
2017
Q4 | $396M | Sell |
4,351,342
-90,263
| -2% | -$7.51M | 0.02% | 848 |
|
|
2017
Q3 | $338M | Buy |
4,441,605
+778,651
| +21% | +$58.8M | 0.02% | 935 |
|
|
2017
Q2 | $275M | Buy |
3,662,954
+805,573
| +28% | +$55.8M | 0.01% | 1063 |
|
|
2017
Q1 | $186M | Buy |
2,857,381
+2,850,894
| +43,948% | +$168M | 0.01% | 1350 |
|
|
2016
Q4 | $358K | Sell |
6,487
-2,011
| -24% | -$110K | ﹤0.01% | 1831 |
|
|
2016
Q3 | $480K | Buy |
8,498
+6,099
| +254% | +$299K | ﹤0.01% | 1751 |
|
|
2016
Q2 | $100K | Buy |
2,399
+495
| +26% | +$22.8K | ﹤0.01% | 2541 |
|
|
2016
Q1 | $81K | Sell |
1,904
-2,914
| -60% | -$123K | ﹤0.01% | 2098 |
|
|
2015
Q4 | $218K | Sell |
4,818
-193
| -4% | -$8.11K | ﹤0.01% | 1641 |
|
|
2015
Q3 | $194K | Sell |
5,011
-7,026
| -58% | -$281K | ﹤0.01% | 1636 |
|
|
2015
Q2 | $437K | Buy |
12,037
+7,561
| +169% | +$239K | ﹤0.01% | 1575 |
|
|
2015
Q1 | $129K | Buy |
4,476
+4,067
| +994% | +$113K | ﹤0.01% | 1741 |
|
|
2014
Q4 | $10K | Buy |
+409
| New | +$9.22K | ﹤0.01% | 2790 |
|
Other funds holding PRAH
BlackRock's PRAH Position: Q3 2021 in Review
BlackRock sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 4,358,664 shares — an estimated $720M sold.
BlackRock first reported a position in PRAH in Q4 2014 and held it in 27 quarters. The position peaked at $1.02B in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- BlackRock reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- BlackRock sold 4,358,664 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $720M.
- BlackRock first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 27 quarters.
- BlackRock's PRA Health Sciences, Inc. position peaked at $1.02B in Q1 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.